| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| A0A024R6Z5 | HCG2026222, isoform CRA_c; | NULL | NULL | 264 | human |
| A0A024QZK5 | MAWD binding protein, isoform CRA_b; | MAWBP; | NULL | 288 | human |
| A0A024R9W8 | Solute carrier family 30 (Zinc transporter), member 9, isoform CRA_b; | SLC30A9; | NULL | 568 | human |
| A0A024R2P4 | Chromosome 3 open reading frame 39, isoform CRA_a; | C3orf39; | NULL | 580 | human |
| A0A024R3C9 | Chromosome 11 open reading frame 65, isoform CRA_b; | C11orf65; | NULL | 313 | human |
| A0A024R6T8 | NEFA-interacting nuclear protein NIP30, isoform CRA_a; | NIP30; | NULL | 254 | human |
| A0A024R6R2 | Glutamic pyruvate transaminase (Alanine aminotransferase) 2, isoform CRA_b; | GPT2; | NULL | 523 | human |
| Q96BS4 | FBL protein; Fragment; | FBL; | NULL | 260 | human |
| A0A024R658 | Zinc finger protein 36, C3H type-like 1, isoform CRA_a; | ZFP36L1; | NULL | 338 | human |
| A0A024R9N2 | Fanconi anemia, complementation group C, isoform CRA_a; | FANCC; | NULL | 558 | human |
| A0A024R588 | Splicing factor 1, isoform CRA_d; | SF1; | NULL | 548 | human |
| A0A024RAN7 | Ankyrin repeat, family A (RFXANK-like), 2, isoform CRA_a; | ANKRA2; | NULL | 313 | human |
| A0A024R1Q5 | N-acetylgalactosaminidase, alpha-, isoform CRA_a; | NAGA; | NULL | 411 | human |
| A0A024R7E1 | Yip1 domain family, member 2, isoform CRA_a; | YIPF2; | NULL | 316 | human |
| A0A024R0L5 | Glycogen synthase kinase 3 alpha, isoform CRA_a; | GSK3A; | NULL | 483 | human |
| A0A024RC92 | Tyrosine-protein kinase; EC 2.7.10.2; | FES; | NULL | 822 | human |
| A0A024QZ60 | Chromosome 17 open reading frame 63, isoform CRA_a; | C17orf63; | NULL | 562 | human |
| Q9UI64 | HCG2003078; PRO0452; Fragment; | NULL | NULL | 34 | human |
| A0A024R9E9 | Frizzled homolog 6 (Drosophila), isoform CRA_a; | FZD6; | NULL | 706 | human |
| A0A024R1P2 | Ras-related C3 botulinum toxin substrate 2 (Rho family, small GTP binding protein Rac2), isoform CRA_a; | RAC2; | NULL | 192 | human |
